Skip to main content
SpringerLink
Log in

Polycystic Ovary Syndrome

  • Chapter
  • First Online:
Amenorrhea

Part of the book series: Contemporary Endocrinology ((COE))

  • 1287 Accesses

Abstarct

Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by the pathogenetic importance of ovarian hyperandrogenism and insulin resistance and by the variable presence of four key features: (1) chronic anovulation; (2) hyperandrogenism; (3) abdominal obesity; and (4) polycystic ovaries [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carmina E, Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897–1899

    Article  PubMed  CAS  Google Scholar 

  2. Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191

    Google Scholar 

  3. Rotterdam ESHRE/ASRM sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25

    Google Scholar 

  4. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF (2006) Position statement: criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenic ­syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91:4237–4245

    Article  PubMed  CAS  Google Scholar 

  5. Carmina E, Azziz R (2006) Diagnosis, phenotype and prevalence of polycystic ovary ­syndrome. Fertil Steril 86(suppl 1):87–89

    Google Scholar 

  6. Azziz R, Woods KS, Reyna R et al (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749

    Article  PubMed  CAS  Google Scholar 

  7. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA (2006) Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2–6

    Article  PubMed  CAS  Google Scholar 

  8. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R (2005) Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 83:1717–1723

    Article  PubMed  Google Scholar 

  9. Carmina E, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the finding of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90:2545–2549

    Article  PubMed  CAS  Google Scholar 

  10. Welt CK, Gudmundsson JA, Arsson G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF (2006) Characterizing discrete subsets of Polycystic Ovary Syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 91:4842–4848

    Article  PubMed  CAS  Google Scholar 

  11. Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P (2006) Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 91:3922–3927

    Article  PubMed  CAS  Google Scholar 

  12. Guastella E, Longo RA, Carmina E (2010) Clinical and endocrine characteristics of main PCOS phenotypes. Fertil Steril Epub March 10

    Article  PubMed  CAS  Google Scholar 

  13. Huber-Buckholz MM, Carey DG, Norman RJ (1999) Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 84:1470–1474

    Article  Google Scholar 

  14. Carmina E, Legro R, Stamets K, Lowell J, Lobo RA (2003) Differences in body weight between American and Italian women with the polycystic ovary syndrome: influence of the diet. Hum Reprod 11:2289–2293

    Article  Google Scholar 

  15. Di Fede G, Mansueto P, Longo RA, Rini G, Carmina E (2009) Influence of sociocultural ­factors on the ovulatory status of polycystic ovary syndrome. Fertil Steril 91:1853–1856

    Article  PubMed  Google Scholar 

  16. Goldzieher JW, Axelrod LR (1963) Clinical and biochemical features of polycystic ovary disease. Fertil Steril 14:631–653

    PubMed  CAS  Google Scholar 

  17. Balen A, Conway GS, Kaltsas G et al (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10:2107–2111

    PubMed  CAS  Google Scholar 

  18. Lobo RA, Carmina E (1997) Polycystic ovary syndrome. In: Lobo RA, Mishell DR Jr, Paulson RJ, Shoupe D (eds) Infertility, contraception and reproductive endocrinology. Blackwell, Malden, pp 362–383

    Google Scholar 

  19. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Di Fede G, Rini GB (2007) Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 92:2500–2505

    Article  PubMed  CAS  Google Scholar 

  20. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA (2009) Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 91:1332–1335

    Article  PubMed  Google Scholar 

  21. Van Hoof MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J (2004) Predictive value of menstrual cycle patter, body mass index, hormone levels and polycystic ovaries for oligo-amenorrhea at age 18 years. Hum Reprod 19:383–392

    Article  Google Scholar 

  22. Wiksten-Almstromer M, Hirschberg AL, Hagenfeldt K (2007) Prospective follow-up of menstrual disorders in adolescence and prognostic features. Acta Obstet Gynecol Scand 87:1162–1168

    Article  Google Scholar 

  23. Sultan C, Paris F (2006) Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril 86(Suppl 1):S6

    Article  PubMed  Google Scholar 

  24. Chen J, Yang D, Li L, Chen X (2008) The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 21:347–350

    Article  PubMed  Google Scholar 

  25. Chang JR, Coffler MS (2007) Polycystic ovary syndrome: early detection in the adolescent. Clin Obstet Gynecol 50:178–187

    Article  Google Scholar 

  26. Thessaloniki ESHRE/ASRM Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23:462–477

    Article  Google Scholar 

  27. Palomba S, Pasquali R, Orio F Jr, Nestler JE (2009) Clomiphene citrate, metformin or both as first step approach in treating anovulatory infertility in patients with polycystic ovary ­syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol (Oxf) 70:311–321

    Article  CAS  Google Scholar 

  28. Begum MR, Ferdous J, Begum A, Qadir E (2009) Comparison of the efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril 92:853–857

    Article  PubMed  CAS  Google Scholar 

  29. Martyn KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori V, Swiglo BA (2008) Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1105–1120

    Article  Google Scholar 

  30. Carmina E (2001) A risk-benefit assessment of pharmacological therapies for hirsutism. Drug Saf 24:267–276

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Biological Sciences, University of Palermo, Via delle Croci 47, 90139, Palermo, Italy

    Enrico Carmina

Authors
  1. Enrico Carmina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Enrico Carmina .

Editor information

Editors and Affiliations

  1. , Department of Obstetrics and Gynecology, University of Colorado Denver School of, Academic Office Building 1, Room 4010, Aurora, 80045, Colorado, USA

    Nanette F. Santoro

  2. , Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Ullman 1211, Bronx, 10461, New York, USA

    Genevieve Neal-Perry

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press

About this chapter

Cite this chapter

Carmina, E. (2010). Polycystic Ovary Syndrome. In: Santoro, N., Neal-Perry, G. (eds) Amenorrhea. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-864-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-864-5_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-863-8

  • Online ISBN: 978-1-60327-864-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation